Still, even if MYC mainly sensitizes the death receptor pathway via regulating BCL-2-family proteins and NFκB, we would expect overexpression of FLIPL to have some impact if the death receptor pathway is important for suppressing AML development. This evidence concerns the gene NFKB1 and acute myeloid leukemia.